secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRATA Skin Sciences, Inc. (SSKN)
CIK:        0001051514
Form:       8-K
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001140361-25-041985
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Strata Skin Sciences Q3 revenue $6.9M (-21% YoY); net loss narrows to $1.6M
---------------------------------------------------------------------------

- Revenue $6.9M (-21% YoY); net loss $1.6M (EPS -$0.36) vs $2.1M loss (EPS -$0.51) last year.
- Global recurring revenue $5.5M (+3% YoY); equipment revenue $1.4M (-60%).
- EBITDA slightly positive vs -$0.2M; cash $7.1M after $2.4M registered direct offering.
- CMS recognized expanded CPT codes for XTRAC; COFEPRIS cleared TheraClearX in Mexico.
- XTRAC install base 838 (-6); TheraClearX 161; avg gross billings per device $5,981 (+8.5%).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125041985/0001140361-25-041985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051514/000114036125041985/ef20058935_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-041985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer